Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
0.556
+0.046 (9.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sol-Gel Technologies Employees
Sol-Gel Technologies had 36 employees as of December 31, 2023. The number of employees decreased by 19 or -34.55% compared to the previous year.
Employees
36
Change (1Y)
-19
Growth (1Y)
-34.55%
Revenue / Employee
$182,194
Profits / Employee
-$414,306
Market Cap
15.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Psychemedics | 116 |
T2 Biosystems | 113 |
Aspira Women's Health | 64 |
Evaxion Biotech | 49 |
Imunon | 33 |
IN8bio | 31 |
QT Imaging Holdings | 14 |
COSCIENS Biopharma | 12 |
SLGL News
- 2 months ago - UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 2 months ago - Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - Sol-Gel Technologies Announces Management Realignment - GlobeNewsWire
- 6 months ago - Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 6 months ago - Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel - GlobeNewsWire
- 7 months ago - Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream - GlobeNewsWire
- 8 months ago - Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments - GlobeNewsWire
- 1 year ago - Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study - GlobeNewsWire